Center Star Asset Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Center Star Asset Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $1.87 Million - $2.06 Million	-25,700 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $1.58 Million - $1.89 Million	25,700 New	25,700 $1.67 Million
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $167,157 - $182,034	-2,700 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $640,872 - $720,792	-10,800 Reduced 80.0%	2,700 $162,000
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $664,010 - $752,445	11,500 Added 575.0%	13,500 $836,000
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $1.05 Million - $1.16 Million	-18,300 Reduced 90.15%	2,000 $122,000
Q3 2019 Oct 24, 2019	BUY	$42.77 - $50.71 $868,231 - $1.03 Million	20,300 New	20,300 $76,000
Q1 2019 Apr 29, 2019	SELL	$45.12 - $53.8 $3.19 Million - $3.8 Million	-70,700 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $126,776 - $164,398	-2,600 Reduced 3.55%	70,700 $121,000
Q3 2018 Oct 15, 2018	BUY	$55.19 - $62.25 $3.77 Million - $4.25 Million	68,300 Added 1366.0%	73,300 $190,000
Q2 2018 Jul 09, 2018	BUY	$50.53 - $62.98 $252,650 - $314,900	5,000 New	5,000 $4,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.